Short communication · 14 Apr 2025
Conference abstractPublished 17 Sep 2018
Sialic acid associated to VEGFR2 of the endothelial cell surface is implicated in VEGF-dependent angiogenesis
University of Brescia, Italy; Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (MI), Italy; University of Genoa, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Sialic acid (NeuAc) is a major anion on the endothelial cell (EC) where, by governing different molecular interactions it modulates important processes including angiogenesis. NeuAc is usually associated to N-glycan linked to various receptors, including the vascular endothelial growth factor receptor-2 (VEGFR2), the main pro-angiogenic receptor on ECs. By means of complementary approaches including computational analysis, surface plasmon resonance, immunoprecipitation, enzymatic digestion, immunofluorescence, cross-linking experiments with sugar-binding lectins and SiRNA targeting sialyltransferases (STs), we demonstrate that VEGFR2 bears both α,1-fucose and α(2,6)-linked sialic acid (NeuAc). However, only the latter is required for VEGF binding to VEGFR2 and consequent VEGF-dependent VEGFR2 activation and motogenic response in ECs. Accordingly, among the various lectin assayed, only the α(2-6)-NeuAc-binding lectin Sambucus nigra (SNA) prevents VEGF-dependent VEGFR2 autophosphorylation, EC motility, proliferation motogenesis. Also, it inhibits VEGF-dependent angiogenesis in the chick-embryo chorioallantoic membrane neovascularization assay and mouse matrigel plug assay in vivo. Interestingly, downregulation of ST6Gal-1 expression by siRNA transduction inhibits VEGFR2 α(2,6)-NeuAc sialylation that is paralleled by an increase of ST3Gal-1 expression that results in an ex-novo α(2,3)-NeuAc sialylation of the receptor that functionally rescues VEGF/VEGFR2 interaction. Since these data point to VEGFR2 sialylation as a target for the treatment of angiogenesis-dependent diseases, we have started an integrated approach made up of in silico, biochemical and biological methodologies to speed up the process of discovery of compounds able to bind the common structural framework involved in catalysis shared by the different STs implicated in the sialylation of VEGFR2, to be evaluated for their anti-angiogenic potential..
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Glycobiology.
Commentary · 11 Apr 2025
The Essential Role of Glycosylation in Biological Processes and Disease Pathogenesis
Commentary · 10 Apr 2025
Exploring the Secrets of Glycomics: Decoding the Complexities of Sugars
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Glycobiology
- BylineArticles whose byline prints “Marco Rusnati”
- BylineArticles whose byline prints “Paola Chiodelli”
- BylineArticles whose byline prints “Giulia Paiardi”
- BylineArticles whose byline prints “Pasqualina D ursi”
- BylineArticles whose byline prints “Alessandro Orro”
- BylineArticles whose byline prints “Matteo Uggeri”
- BylineArticles whose byline prints “Paola Fossa”
